DR. ZEIL ROSENBERG, MD
Medical Practice at Yale Pl, Closter, NJ
License number
New Jersey 25MA07334200
Category
Medical Practice
Type
Public Health & General Preventive Medicine
Address
Address
40 Yale Pl, Closter, NJ 07624
Phone
(646) 402-5289
(646) 390-3238 (Fax)
(646) 390-3238 (Fax)
Personal information
See more information about ZEIL ROSENBERG at radaris.comName
Address
Phone
40 Yale Pl, Closter, NJ 07624
40 Yale Pl, Closter, NJ 07624
40 Yale Pl, Closter, NJ 07624
Organization information
See more information about ZEIL ROSENBERG at bizstanding.comZeil Rosenberg MD
40 Yale Pl, Closter, NJ 07624
Categories:
Physicians & Surgeons
Phone:
(646) 402-5289 (Phone)
Professional information
Method And Apparatus For The Transdermal Administration Of A Substance
US Patent:
6623457, Sep 23, 2003
Filed:
Sep 22, 1999
Appl. No.:
09/401452
Inventors:
Zeil B. Rosenberg - Closter NJ
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
A61M 500
US Classification:
604191, 604272
Abstract:
A transdermal delivery device includes a plurality of microneedles for injecting a substance such as a pharmaceutical agent into or below the stratum corneum of the skin. The device has housing formed from a top and bottom wall to define a chamber for containing a pharmaceutical agent. An inlet port is provided in the top wall of the housing for supplying the pharmaceutical agent to the chamber and directing the agent to the microneedles. The housing can have a Luer lock type fitting for coupling with a syringe having a Luer lock collar to inject the pharmaceutical agent into the housing. The housing can be divided into a plurality of chambers by an internal wall for supplying different agents simultaneously or sequentially to a patient. The microneedles have a length of about 5-250 microns and generally about 50-100 microns.
Method And Apparatus For The Transdermal Administration Of A Substance
US Patent:
6960193, Nov 1, 2005
Filed:
May 20, 2003
Appl. No.:
10/441035
Inventors:
Zeil B. Rosenberg - Closter NJ, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
A61M005/00
US Classification:
604191, 604272
Abstract:
A transdermal delivery device includes a plurality of microneedles for injecting a substance such as a pharmaceutical agent into or below the stratum corneum of the skin. The device has housing formed from a top and bottom wall to define a chamber for containing a pharmaceutical agent. An inlet port is provided in the top wall of the housing for supplying the pharmaceutical agent to the chamber and directing the agent to the microneedles. The housing can have a Luer lock type fitting for coupling with a syringe having a Luer lock collar to inject the pharmaceutical agent into the housing. The housing can be divided into a plurality of chambers by an internal wall for supplying different agents simultaneously or sequentially to a patient. The microneedles have a length of about 5–250 microns and generally about 50–100 microns.
System For Collecting, Storing, Presenting And Analyzing Immunization Data Having Remote Stations In Communication With A Vaccine And Disease Database Over A Network
US Patent:
7908155, Mar 15, 2011
Filed:
Feb 26, 2003
Appl. No.:
10/373590
Inventors:
Oren Fuerst - New York NY, US
Zeil Rosenberg - Closter NJ, US
Zeil Rosenberg - Closter NJ, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
G06Q 50/00, G06Q 10/00
US Classification:
705 3, 705 2
Abstract:
A system is provided for collecting and storing immunization and disease data. Immunization mobile stations (IMSs) are provided with a software application to facilitate the collection of patient information such as biographical data, previous vaccination data, medical history, medications in use, occupation, administration of recent vaccination, disease symptoms and the like. IMSs synchronize the patient information with information stored in a database maintained at a data center that is accessible to different groups of personnel based on different privileges defined at the data center and security measures. Patients can access electronic patient records created by the IMSs, and stored at the IMSs and/or a local server and eventually at the data center, via telephone or computer (e. g. , via web browser). IMSs can capture and store images of vaccination and disease symptom sites on patients.
Method And Apparatus For The Transdermal Administration Of A Substance
US Patent:
2006004, Mar 2, 2006
Filed:
Oct 7, 2005
Appl. No.:
11/245618
Inventors:
Zeil Rosenberg - Closter NJ, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
A61B 17/20
US Classification:
604047000
Abstract:
A transdermal delivery device includes a plurality of microneedles for injecting a substance such as a pharmaceutical agent into or below the stratum corneum of the skin. The device has housing formed from a top and bottom wall to define a chamber for containing a pharmaceutical agent. An inlet port is provided in the top wall of the housing for supplying the pharmaceutical agent to the chamber and directing the agent to the microneedles. The housing can have a Luer lock type fitting for coupling with a syringe having a Luer lock collar to inject the pharmaceutical agent into the housing. The housing can be divided into a plurality of chambers by an internal wall for supplying different agents simultaneously or sequentially to a patient. The microneedles have a length of about 5-250 microns and generally about 50-100 microns.
Method And Apparatus For The Transdermal Administration Of A Substance
US Patent:
2008028, Nov 20, 2008
Filed:
Jul 30, 2008
Appl. No.:
12/182432
Inventors:
Zeil B. Rosenberg - Closter NJ, US
International Classification:
A61M 5/31, A61M 5/19, A61M 5/32
US Classification:
604 60, 604207, 604191, 604180, 604192, 604 92
Abstract:
A transdermal delivery device includes a plurality of microneedles for injecting a substance such as a pharmaceutical agent into or below the stratum corneum of the skin. The device has housing formed from a top and bottom wall to define a chamber for containing a pharmaceutical agent. An inlet port is provided in the top wall of the housing for supplying the pharmaceutical agent to the chamber and directing the agent to the microneedles. The housing can have a Luer lock type fitting for coupling with a syringe having a Luer lock collar to inject the pharmaceutical agent into the housing. The housing can be divided into a plurality of chambers by an internal wall for supplying different agents simultaneously or sequentially to a patient. The microneedles have a length of about 5-250 microns and generally about 50-100 microns.
Methods And Compositions Using Anti-Lps Ligands For The Treatment And Prevention Of Inflammatory Disorders
US Patent:
2013027, Oct 17, 2013
Filed:
Oct 4, 2011
Appl. No.:
13/877780
Inventors:
Grant Thomas Rawlin - Kilmore East, AU
Zeil Rosenberg - Closter NJ, US
Oren Fuerst - New York NY, US
Zeil Rosenberg - Closter NJ, US
Oren Fuerst - New York NY, US
Assignee:
IMMURON LIMITED - North Melbourne, Victoria
International Classification:
A61K 39/40, A61K 45/06
US Classification:
4241641, 5303875
Abstract:
The present invention provides methods and compositions useful in the field of medicine, and particularly in the treatment of inflammatory disorders. More particularly, the invention relates to the use of methods and compositions for the treatment and prevention of disorders associated with inflammation of alimentary tract, such as human immunodeficiency virus (HIV) infection and ulcerative colitis and Crohn's disease.